Emmecell
PrivateLast Round
Strategic
Jun 16, 2026
Total Funding Raised
$46M
Company Overview
Emmecell is a biotechnology company that develops cell-based therapies for the treatment of eye diseases using its proprietary Magnetic Cell Delivery (MCD) nanoparticle platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Emmecell Comparables
Compare Emmecell with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Trefoil Therapeutics | 81% | |
| ActualEyes, Inc. | 80% | |
| Cellusion Inc. | 80% | |
Emmecell Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Jun 16, 2026 | ||||
| Series A | Jan 19, 2026 |
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 23, 2026
Monthly visitors grew 71% MoM, reaching 2.2K.
- Nov 6, 2025
Monthly visitors increased 80% MoM.
Emmecell Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Emmecell's valuation, stock price, and market status.